Figure S4.
Summary of gene pathway analysis of GEPNEC vs. LNEC. (A) Oncoprints of main pathways with alteration frequency among GEPNEC and LNEC patients; (B) Bar plots of pathway alteration proportions of GEPNEC vs. LNEC. GEPNEC, gastroenteropancreatic neuroendocrine carcinoma; LNEC, lung NEC. P values were determined using Fisher’s exact test. *, P<0.05; ***, P<0.001.